blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2279774

EP2279774 - Catheter with enhanced pushability [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.06.2017
Database last updated on 13.04.2024
Most recent event   Tooltip20.07.2018Lapse of the patent in a contracting state
New state(s): MT		published on 22.08.2018  [2018/34]
Applicant(s)For all designated states
Abbott Laboratories Vascular Enterprises Limited
Earlsfort Center Terrace
Dublin 2 / IE
[2011/05]
Inventor(s)01 / Jeffrey, Andrew
Münzgasse 16
72070 Tübingen / DE
02 / Lacken, John P.
August-Bebel-Strasse 10
72072 Tübingen / DE
 [2011/05]
Representative(s)Peters, Hajo, et al
ZACCO GmbH
Bayerstrasse 83
80335 München / DE
[2016/30]
Former [2011/05]Peters, Hajo, et al
Albihns Zacco GmbH Bayerstrasse 83
80335 München / DE
Application number, filing date09009804.729.07.2009
[2011/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2279774
Date:02.02.2011
Language:EN
[2011/05]
Type: B1 Patent specification 
No.:EP2279774
Date:27.07.2016
Language:EN
[2016/30]
Search report(s)(Supplementary) European search report - dispatched on:EP15.01.2010
ClassificationIPC:A61M25/00, // A61M25/10
[2011/05]
CPC:
A61M25/005 (EP,US); A61M25/0051 (EP,US); A61M2025/0059 (EP,US);
A61M25/1006 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/30]
Former [2011/05]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Katheter mit verbesserter Vorschiebbarkeit[2011/05]
English:Catheter with enhanced pushability[2011/05]
French:Cathéter avec poussée améliorée[2011/05]
Examination procedure02.08.2011Examination requested  [2011/37]
23.08.2011Despatch of a communication from the examining division (Time limit: M04)
01.12.2011Reply to a communication from the examining division
10.02.2012Despatch of a communication from the examining division (Time limit: M04)
09.05.2012Reply to a communication from the examining division
24.08.2012Despatch of a communication from the examining division (Time limit: M04)
22.11.2012Reply to a communication from the examining division
19.02.2016Communication of intention to grant the patent
16.06.2016Fee for grant paid
16.06.2016Fee for publishing/printing paid
16.06.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.08.2011
Opposition(s)02.05.2017No opposition filed within time limit [2017/27]
Fees paidRenewal fee
16.07.2011Renewal fee patent year 03
10.07.2012Renewal fee patent year 04
08.07.2013Renewal fee patent year 05
08.07.2014Renewal fee patent year 06
09.07.2015Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.07.2009
AT27.07.2016
BE27.07.2016
CY27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
MK27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
TR27.07.2016
IE29.07.2016
LU29.07.2016
CH31.07.2016
LI31.07.2016
MT31.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
[2018/33]
Former [2018/29]HU29.07.2009
AT27.07.2016
BE27.07.2016
CY27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
MK27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
TR27.07.2016
IE29.07.2016
LU29.07.2016
CH31.07.2016
LI31.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2018/28]HU29.07.2009
AT27.07.2016
BE27.07.2016
CY27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
MK27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
IE29.07.2016
LU29.07.2016
CH31.07.2016
LI31.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/37]AT27.07.2016
BE27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
IE29.07.2016
LU29.07.2016
CH31.07.2016
LI31.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/32]AT27.07.2016
BE27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SK27.07.2016
SM27.07.2016
IE29.07.2016
CH31.07.2016
LI31.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/24]AT27.07.2016
BE27.07.2016
CZ27.07.2016
DK27.07.2016
EE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
NL27.07.2016
PL27.07.2016
RO27.07.2016
SE27.07.2016
SK27.07.2016
SM27.07.2016
CH31.07.2016
LI31.07.2016
BG27.10.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/20]AT27.07.2016
BE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
NL27.07.2016
PL27.07.2016
SE27.07.2016
CH31.07.2016
LI31.07.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/13]AT27.07.2016
BE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
LV27.07.2016
NL27.07.2016
PL27.07.2016
SE27.07.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/11]AT27.07.2016
BE27.07.2016
ES27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
NL27.07.2016
PL27.07.2016
SE27.07.2016
NO27.10.2016
GR28.10.2016
IS27.11.2016
PT28.11.2016
Former [2017/10]BE27.07.2016
FI27.07.2016
HR27.07.2016
IT27.07.2016
LT27.07.2016
NL27.07.2016
PL27.07.2016
SE27.07.2016
NO27.10.2016
IS27.11.2016
Former [2017/09]FI27.07.2016
IT27.07.2016
LT27.07.2016
NL27.07.2016
BE31.07.2016
NO27.10.2016
Former [2017/07]LT27.07.2016
BE31.07.2016
Former [2017/03]BE31.07.2016
Documents cited:Search[X]WO03035159  (SCIMED LIFE SYSTEMS INC [US]) [X] 1,2,4,6-10 * page 1, line 4 - page 1, line 6 * * page 1, line 30 - page 2, line 18 * * page 3, line 6 - page 6, line 19; figures 1-6 *;
 [X]US2002095203  (THOMPSON PAUL J [US], et al) [X] 1-7 * page 1, paragraph 3 * * page 1, paragraph 14 * * page 5, paragraph 70 - page 7, paragraph 91; figures 8-14 * * page 7, paragraph 101; figures 23,24 *;
 [X]WO2007054364  (ABBOTT LAB VASCULAR ENTPR LTD [IE], et al) [X] 1,3,8-10 * page 1, line 15 - page 1, line 18 * * page 8, line 5 - page 8, line 9; figure 9 *;
 [A]US2007244550  (EIDENSCHINK TRACEE [US]) [A] 1-4,8-10 * page 1, paragraph 15 - page 2, paragraph 15 * * page 3, paragraph 36; figures 4A,4B * * page 3, paragraph 37; figures 5A,5B * * page 3, paragraph 38; figures 6A,6B *;
 [A]EP0551184  (DANFORTH BIOMEDICAL INC [US]) [A] 1-3 * column 1, line 1 - column 1, line 4 * * column 2, line 18 - column 3, line 2 * * column 5, line 45 - column 6, line 34 * * column 8, line 16 - column 8, line 24 * * column 9, line 41 - column 10, line 48 * * column 13, line 44 - column 15, line 46; figures 1A,1B *;
 [A]EP0452901  (TERUMO CORP [JP]) [A] 1-7 * column 2, line 7 - column 2, line 40 * * column 3, line 23 - column 5, line 9; figures 1,2,4,5,7,8 *
by applicantUS5626600
 US5085636
 US5492532
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.